Trending storyWatching
Safety and immunogenicity of a first-generation modified vaccinia virus Ankara-vectored SARS-CoV-2 vaccine candidate with mRNA-based booster vaccination: A phase 1 trial
1 report1 sourceupdated 1 day ago
Start here
No synthesis yet — start with the coverage timeline below.
Coverage timeline
Follow the coverage to see the different angles.
Heat trend for this story
Not enough continuous observation yet to draw a trend.